Should a 67-year-old African American man with hypertension who is taking lisinopril 40 mg daily and furosemide (Lasix) 40 mg daily, and who has persistent elevated systolic blood pressure, be started on a calcium channel blocker?

Yes, Add a Calcium Channel Blocker Now

This 67-year-old African American man with uncontrolled hypertension (SBP 150-170 mmHg) on lisinopril 40mg and furosemide 40mg should be started on a calcium channel blocker immediately. This recommendation is based on the 2020 International Society of Hypertension guidelines, which specifically address treatment algorithms for Black patients with hypertension 1.

Why a Calcium Channel Blocker is the Right Choice

Race-Specific Treatment Considerations

The most recent guidelines (2020 ISH) provide clear, race-specific treatment pathways. For Black patients, the recommended initial therapy is either a low-dose ARB combined with a DHP-CCB, OR a DHP-CCB combined with a thiazide/thiazide-like diuretic 1. Since this patient is already on an ACE inhibitor (lisinopril, which is similar to an ARB in mechanism) and a loop diuretic (furosemide), adding a calcium channel blocker completes the preferred three-drug combination for Black patients.

The 2017 ACC/AHA guidelines reinforce this approach, noting that thiazide diuretics or CCBs are more effective in lowering BP than RAS inhibitors or beta blockers in Black patients and are more effective in reducing cardiovascular events 2. The guidelines explicitly state that ACE inhibitors and ARBs are less effective as monotherapy in Black patients but work well in combination regimens that include CCBs or diuretics 2, 3.

Current Medication Assessment

Important caveat: This patient is on furosemide (Lasix), a loop diuretic, rather than a thiazide or thiazide-like diuretic. The guidelines consistently recommend thiazide-type diuretics (chlorthalidone 12.5-25mg or hydrochlorothiazide 25-50mg) over loop diuretics for hypertension management 4, 2. Loop diuretics are generally reserved for patients with heart failure or significant fluid overload. Unless this patient has heart failure or volume overload requiring a loop diuretic, consider switching from furosemide to a thiazide-like diuretic (such as chlorthalidone) when adding the CCB.

Specific Drug Selection

Start with amlodipine 5mg once daily (a dihydropyridine CCB). The evidence shows:

• Amlodipine is as effective as chlorthalidone and more effective than lisinopril in reducing BP and cardiovascular events in diverse populations 2
• The combination of amlodipine with lisinopril produces significant additional BP lowering compared to either agent alone 5, 6
• Once-daily dosing improves compliance 6

Treatment Algorithm for This Patient

1. Add amlodipine 5mg once daily to the current regimen
2. Consider switching furosemide 40mg to chlorthalidone 12.5-25mg daily (unless heart failure or volume overload is present)
3. Reassess BP in 2-4 weeks 4
4. If BP remains uncontrolled, increase amlodipine to 10mg daily (maximum dose)
5. Target BP: <130/80 mmHg (or <140/90 mmHg if frail) 1
6. Achieve target within 3 months 1

Evidence Strength

The 2020 ISH guidelines [1-1] represent the most recent, high-quality evidence specifically addressing race-based treatment algorithms. These guidelines are more recent than the 2017 ACC/AHA guidelines 2 and provide more explicit race-specific recommendations. The combination therapy approach (ACE inhibitor/ARB + CCB + thiazide diuretic) is consistently recommended across multiple international guidelines 4, 1, 2.

Common Pitfalls to Avoid

• Don't delay adding the CCB: The patient has had elevated BP for 72 hours and is already on two agents. Waiting longer increases cardiovascular risk.
• Watch for peripheral edema: CCBs can cause ankle swelling 7. If this occurs, it's a side effect of the CCB, not a new medical condition requiring a diuretic (prescribing cascade).
• Don't use non-dihydropyridine CCBs (diltiazem, verapamil) with beta-blockers due to additive cardiac effects—stick with dihydropyridines like amlodipine.
• Ensure medication adherence: Check that the patient is actually taking the lisinopril and furosemide as prescribed before adding another agent 1.

Lisinopril Dosing Consideration

The patient is on lisinopril 40mg once daily, which is the maximum dose. However, lisinopril may be less effective in Black patients 2, 8, 3. One study showed that twice-daily dosing of lisinopril (20mg BID vs 40mg once daily) produced greater BP reductions 9, but given the race-specific reduced efficacy, adding a CCB is more appropriate than adjusting lisinopril dosing.